Why Many Drugs Remain Pricey 40 Years After Hatch-Waxman
By Hannah Albarazi · September 27, 2024, 7:17 PM EDT
In the four decades since Congress passed the Hatch-Waxman Act in an effort to make generic drugs more available, the pharmaceutical industry has used patent thickets, "evergreening" and pay-for-delay tactics to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login